AAOI vs CURI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

AAOI

39.8
AI Score
VS
CURI Wins

CURI

41.0
AI Score

Investment Advisor Scores

AAOI

40score
Recommendation
SELL

CURI

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AAOI CURI Winner
Forward P/E 84.0336 13.7741 CURI
PEG Ratio 0.775 0 Tie
Revenue Growth 86.4% 22.3% AAOI
Earnings Growth 0.0% 1400.0% CURI
Tradestie Score 39.8/100 41.0/100 CURI
Profit Margin -9.6% 0.0% CURI
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD CURI

Relative Price Performance (Last 90 Days)

AAOI 1M: +7.5% · 3M: -40.7% CURI 1M: +20.9% · 3M: +11.4%

Current Technical Phase

AAOI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.5%), weak momentum, RSI 43

RSI (14): 42.9 · Price: $107.63

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $2.84

Fundamentals Snapshot

Metric AAOI CURI
Market Cap
Forward P/E 23.4 9.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.9% 0.2%
Gross Margin 0.3% 0.6%
Operating Margin -0.1% 0.4%
EPS -0.77 -0.01
Dividend Yield 0.11%

Frequently Asked Questions

Based on our detailed analysis, CURI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.